#Moderna, #Coronavirus, #Vaccine, #COVID19
Washington/Canadian-Media: The results of its corona vaccine trials by the pharmaceutical company Moderna have been submitted to the US Food and Drug Administration (FDA) in order to obtain emergency use authorization for the vaccine, media reports said.
Moderna Vaccine. Image credit: Twitter handle
Moderna said that vaccine is generally well tolerated and devoid of serious safety concerns and vaccine efficacy was 94.1 percent and reached 100 percent in severe COVID-19 cases.
At least three promising vaccine candidates are expected to receive emergency use authorization from US health authorities in coming weeks, according to media reports.
The U.S. FDA said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effective vaccine likely to receive U.S. regulatory backing and a potential roll out this year.